普萘洛尔与可乐定对液压颅脑损伤大鼠脑水肿、血脑屏障通透性及内皮糖萼破坏的影响
该研究将53只成年雄性Sprague-Dawley大鼠随机分为普萘洛尔组(n=16)、普萘洛尔+可乐定组(n=16)、溶剂对照组(n=16)和假手术组(n=5),持续输注24小时。主要终点24小时脑水含量在普萘洛尔组(80.8±0.3%;95%CI 80.7-81.0)与溶剂对照组(81.1±0.6%;95%CI 80.8-81.4)间无差异(p=0.668),普萘洛尔+可乐定组(80.8±0.3%;95%CI 80.7-81.0)与溶剂对照组间亦无差异(p=0.555)。普萘洛尔及联合可乐定对血脑屏障通透性和动物运动评分无影响,但意外导致肾上腺素和syndecan-1水平升高。作者认为该研究不支持使用非选择性β受体阻滞剂普萘洛尔或联合α2受体激动剂可乐定来降低脑水含量,肾上腺素和syndecan-1升高的意义尚不明确,需进一步研究。
要点
- 在大鼠液压颅脑损伤模型中,普萘洛尔组24小时脑水含量80.8±0.3%(95%CI 80.7-81.0)与溶剂对照组81.1±0.6%(95%CI 80.8-81.4)无差异(p=0.668)。
- 普萘洛尔+可乐定组24小时脑水含量80.8±0.3%(95%CI 80.7-81.0)与溶剂对照组无差异(p=0.555)。
- 普萘洛尔及普萘洛尔+可乐定对血脑屏障通透性和动物运动评分均无影响。
- 普萘洛尔及普萘洛尔+可乐定意外导致血浆肾上腺素和syndecan-1水平升高。
- 作者认为该研究不支持用普萘洛尔或普萘洛尔联合可乐定降低脑水含量,肾上腺素和syndecan-1升高的意义尚不明确,需进一步研究。
适用人群与场景
- 成年雄性Sprague-Dawley大鼠,接受侧方液压颅脑损伤。
研究设计与关键结果
- 研究类型:动物实验;样本量:53只成年雄性Sprague-Dawley大鼠;分组:普萘洛尔组(n=16)、普萘洛尔+可乐定组(n=16)、溶剂对照组(n=16)、假手术组(n=5),持续输注24小时。
- 主要终点:24小时脑水含量,普萘洛尔组80.8±0.3%(95%CI 80.7-81.0)vs 溶剂对照组81.1±0.6%(95%CI 80.8-81.4),p=0.668;普萘洛尔+可乐定组80.8±0.3%(95%CI 80.7-81.0)vs 溶剂对照组,p=0.555。
- 次要终点:普萘洛尔及普萘洛尔+可乐定对血脑屏障通透性和动物运动评分无影响;普萘洛尔及普萘洛尔+可乐定导致肾上腺素和syndecan-1水平升高。
证据类型、等级与局限
- 证据类型:动物实验(大鼠模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,该研究不支持使用非选择性β受体阻滞剂普萘洛尔或普萘洛尔联合α2受体激动剂可乐定来降低脑水含量。
- 作者指出,普萘洛尔治疗后血浆肾上腺素和syndecan-1浓度升高的新发现意义尚不明确,需进一步研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Traumatic brain injury causes a disruption of the vascular endothelial glycocalyx layer that is associated with an overactivation of the sympathoadrenal system. We hypothesized that early and unselective beta-blockade with propranolol alone or in combination with the alfa2-agonist clonidine would decrease brain edema, blood-brain barrier permeability, and glycocalyx disruption at 24 hours after trauma.
METHODS: We subjected 53 adult male Sprague-Dawley rats to lateral fluid percussion brain injury and randomized infusion with propranolol (n = 16), propranolol + clonidine (n = 16), vehicle (n = 16), or sham (n = 5) for 24 hours. Primary outcome was brain water content at 24 hours. Secondary outcomes were blood-brain barrier permeability and plasma levels of syndecan-1 (glycocalyx disruption), cell damage (histone-complexed DNA fragments), epinephrine, norepinephrine, and animal motor function.
RESULTS: We found no difference in brain water content (mean ± SD) between propranolol (80.8 ± 0.3%; 95% confidence interval [CI], 80.7-81.0) and vehicle (81.1 ± 0.6%; 95% CI, 80.8-81.4) (p = 0.668) or between propranolol/clonidine (80.8 ± 0.3%; 95% CI, 80.7-81.0) and vehicle (p = 0.555). We found no effect of propranolol and propranolol/clonidine on blood-brain barrier permeability and animal motor scores. Unexpectedly, propranolol and propranolol/clonidine caused an increase in epinephrine and syndecan-1 levels.
CONCLUSION: This study does not provide any support for unselective beta-blockade with propranolol or the combination of propranolol and the alfa2-agonist clonidine on brain water content. The novel finding of an increase in plasma concentrations of epinephrine and syndecan-1 after propranolol treatment in traumatic brain injury is of unclear significance and should be investigated further.
参考来源
- Genét GF, Bentzer P, Hansen MB, et al. Effects of propranolol and clonidine on brain edema, blood-brain barrier permeability, and endothelial glycocalyx disruption after fluid percussion brain injury in the rat. J Trauma Acute Care Surg. 2018. PMID: 28930945. doi:10.1097/TA.0000000000001708
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。